BioCentury
ARTICLE | Clinical News

ALX-0171: Phase I started

July 15, 2013 7:00 AM UTC

Ablynx began an open-label, German Phase I trial to evaluate single escalating-doses and repeated inhalations of ALX-0171 in about 24 adults with hyper-responsive airways. Ablynx plans to start testin...